Where to invest $50,000 in ASX shares

Analysts think these shares could be great destinations for your hard-earned money.

| More on:
A happy young couple lie on a wooden deck using a skateboard for a pillow.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

sdf

If you are lucky enough to be sitting on $50,000 and wondering how to put it to work in the share market, then read on.

With interest rates falling and long-term growth back in focus, now could be a great time to build a high-quality ASX share portfolio aimed at capital appreciation.

But rather than chasing short-term trades or speculative names, investors may want to consider businesses with proven track records, strong global expansion, and resilient earnings.

With that in mind, here are five standout ASX shares that analysts think could form the foundation of a smart, long-term portfolio. They are as follows:

Cochlear Ltd (ASX: COH)

Cochlear is a global leader in hearing implants technology. With an ageing global population and rising rates of hearing loss, demand for Cochlear's products is only expected to increase over the next decade. The company also invests heavily in R&D, which keeps it ahead of the pack with next-generation devices.

Last week, UBS upgraded its shares to a buy rating with a $325.00 price target.

REA Group Ltd (ASX: REA)

Another ASX share to look at with the $50,000 is REA Group. It is the name behind realestate.com.au, which dominates the online property advertising space in Australia. While the housing market moves in cycles, REA Group has built an incredibly sticky platform with pricing power and deep competitive moats.

Bell Potter is bullish on REA Group and has a buy rating and $267.00 price target on its shares.

ResMed Inc. (ASX: RMD)

ResMed is a major player in the treatment of obstructive sleep apnoea and other sleep and breathing disorders. While concerns around weight-loss drugs spooked the market last year, ResMed has continued to post strong results, including robust mask sales, margin expansion, and double-digit earnings growth. It also benefits from an ageing population and increasing awareness of sleep health.

Macquarie has an outperform rating and $48.00 price target on this ASX share.

WiseTech Global Ltd (ASX: WTC)

WiseTech could be an ASX share to buy with the $50,000. It is a global logistics software provider, best known for its CargoWise platform. It serves some of the world's largest freight forwarders and is capitalising on the structural shift toward digital supply chain management. Recurring revenue, global customer wins, and ongoing product innovation give WiseTech a long runway for growth.

The team at Macquarie has an outperform rating and $152.70 price target on its shares.

Xero Ltd (ASX: XRO)

Finally, Xero could be worth considering. It offers cloud-based accounting software to small and medium-sized businesses. It is one of the most recognisable tech names in the region, with a sticky, subscription-based model and strong international growth potential. And with 4.4 million subscribers on its platform and an estimated 100 million total addressable market, it still has a very long growth runway.

Morgan Stanley has an overweight rating and $220.00 price target on its shares.

Motley Fool contributor James Mickleboro has positions in Cochlear, REA Group, ResMed, WiseTech Global, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear, Macquarie Group, ResMed, WiseTech Global, and Xero. The Motley Fool Australia has positions in and has recommended Macquarie Group, ResMed, WiseTech Global, and Xero. The Motley Fool Australia has recommended Cochlear. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A smiling man take a big bite out of a burrito
Growth Shares

Looking for ASX growth shares? I rate these 2 as buys

I’m backing these investments to deliver big returns.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Growth Shares

Macquarie says these ASX 200 growth shares can rise 20% to 35%

Let's see what the broker is saying about these growing companies.

Read more »

Growth Shares

Why Zip shares and this ASX 200 stock are a buy according to this fund manager

These stocks could be leading contenders to deliver returns in the ASX 200.

Read more »

A man working in the stock exchange.
Growth Shares

Buy these 2 impressive ASX 300 shares in July: experts

Experts are bullish on these stocks.

Read more »

A young man sits at his desk working on his laptop with a big smile on his face.
Growth Shares

1 of the best ASX growth stocks to consider buying in July

I’m calling this stock one of the leading growth opportunities.

Read more »

a group of tech people gather around a computer operated by a young woman while the group looks on in support.
Growth Shares

3 of the best Australian stocks to buy and hold forever

These high-quality shares are rated as buys by brokers for a reason.

Read more »

$100 Australian notes on top of each other.
Growth Shares

Where to invest $10,000 into ASX shares in July

Analysts are raving about these shares. But why are they buys?

Read more »

Four piles of coins, each getting higher, with trees on them.
Growth Shares

2 ASX growth shares to buy this month: experts

These stocks are expected to have a strong next few years…

Read more »